AIRS vs. CELC, EHAB, INNV, PSNL, VMD, LFMD, DCGO, TOI, SERA, and CORBF
Should you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include Celcuity (CELC), Enhabit (EHAB), InnovAge (INNV), Personalis (PSNL), Viemed Healthcare (VMD), LifeMD (LFMD), DocGo (DCGO), Oncology Institute (TOI), Sera Prognostics (SERA), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry.
AirSculpt Technologies vs.
AirSculpt Technologies (NASDAQ:AIRS) and Celcuity (NASDAQ:CELC) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.
Celcuity received 330 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 67.79% of users gave Celcuity an outperform vote while only 35.48% of users gave AirSculpt Technologies an outperform vote.
In the previous week, Celcuity had 1 more articles in the media than AirSculpt Technologies. MarketBeat recorded 5 mentions for Celcuity and 4 mentions for AirSculpt Technologies. Celcuity's average media sentiment score of 1.25 beat AirSculpt Technologies' score of 0.47 indicating that Celcuity is being referred to more favorably in the news media.
AirSculpt Technologies currently has a consensus price target of $3.75, indicating a potential upside of 67.41%. Celcuity has a consensus price target of $30.17, indicating a potential upside of 168.87%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than AirSculpt Technologies.
91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 76.6% of AirSculpt Technologies shares are owned by insiders. Comparatively, 15.8% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
AirSculpt Technologies has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.
Celcuity has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -4.13%. AirSculpt Technologies' return on equity of 2.22% beat Celcuity's return on equity.
AirSculpt Technologies has higher revenue and earnings than Celcuity. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.
Summary
Celcuity beats AirSculpt Technologies on 10 of the 18 factors compared between the two stocks.
Get AirSculpt Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AirSculpt Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:AIRS) was last updated on 4/30/2025 by MarketBeat.com Staff
Buy AIRS Stock Free AIRS Stock Alerts